Mayer Brown advised the Crystal Group on all the employment aspects of the acquisition of Héron Conseil

The Paris Employment & Benefits team provided guidance on all employment-related elements of the acquisition of Héron Conseil (previously COREP) by its private wealth management business Laplace to Crystal firm, the top independent wealth management firm in France with €28 billion in assets under advisement.

Read More

Elisa Roeseler Joins Barclay Damon

Elisa Roeseler, an associate, has joined Barclay Damon’s Trusts & Estates Practice Area. Rochester is her main office.

Read More

Dentons advises NanoStruct on €2.6 million seed financing round

NanoStruct GmbH, a deep-tech business, has once again received advice from the international legal firm Dentons on a €2.6 million seed funding round. The AUXXO Female Catalyst Fund, Bayern Kapital, and High-Tech £erfonds (HTGF) are leading the funding round. The money expands on earlier grants from the European Union and the Federal Ministry for Economic…

Read More

Nashville Litigator Brings Growing Practice to Spencer Fane

With great pleasure, Spencer Fane LLP welcomes Grace Benitone Burnett as an associate in the Litigation and Dispute Resolution Practice Group at its Nashville, Tennessee, office.

Read More

Hogan Lovells advises FinDev Canada in US$30 million loan to CIFI to support economic growth in Latin America and the Caribbean

FinDev Canada has received advice from international legal firm Hogan Lovells regarding a US$30 million loan to Corporación Interamericana para el Financiamiento de Infraestructura (CIFI), a prominent middle-market infrastructure and energy investment platform that provides financial solutions throughout Latin America and the Caribbean.

Read More

Hogan Lovells advises Angelini Pharma as it acquires Catalyst Pharmaceuticals for US$4.1 billion

International pharmaceutical business Angelini Pharma S.p.A. (“Angelini Pharma”) has received advice from global law firm Hogan Lovells on its impending acquisition of Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX) for US$31.50 per share in cash, for a total equity value of roughly US$4.1 billion.

Read More

Gibson Dunn Represented BVP Forge-Backed Medisolv in Acquisitions of Health Elements AI and Lilac Software

In the purchases of Health Elements AI and Lilac Software, Gibson Dunn represented Medisolv, a national leader in healthcare quality data management supported by BVP Forge. One of the top suppliers of AI-first software that automates the abstraction of medical data for clinical registries and quality reporting is Health Elements AI. One of the top…

Read More